Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis.
Cara A RosenbaumUmut ÖzbekLarysa SanchezJonathan LagdameoAlex AbrahamsHani HassounOscar LahoudRuben NiesvizkyHeather J LandauKeren OsmanPublished in: Blood advances (2022)